Related Experiment Video
Updated: Jan 29, 2026
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Gene therapy for thyroid cancer
Augusto Taccaliti1, Monia Pacenti2, Matteo Bruglia3
1a Division of Endocrinology, University of Ancona, Via Conca, I-60100, Ancona, Italy. a.taccaliti@univpm.it.
Abstract:
Although most thyroid cancers may be cured by surgery and 131I therapy, approximately 10-20% of patients die from advanced differentiated and anaplastic tumors that are unresponsive to conventional treatments. Thus, alternative approaches such as gene therapy are of interest, especially using targeted therapeutic gene delivery. Several strategies have been designed specifically for thyroid cancer and some have proven to be feasible in preclinical studies. In particular, it is suggested that combined gene therapy approaches, as well as multimodality therapeutic regimens, including gene therapy and conventional treatments, should be pursued to achieve clinically significant results. The recent discovery of new markers of thyroid cancer should improve the efficacy of gene therapy.
Insights
Gene therapy offers a promising alternative for advanced thyroid cancers resistant to conventional treatments. Combining gene therapy with existing methods may improve patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Most thyroid cancers are treatable with surgery and radioactive iodine (I-131).
- A significant minority (10-20%) of patients develop advanced tumors unresponsive to standard therapies.
- This necessitates exploring novel treatment strategies for refractory thyroid cancer.
Purpose of the Study:
- To review the potential of gene therapy for advanced thyroid cancer.
- To highlight the feasibility of targeted therapeutic gene delivery in preclinical models.
- To emphasize the importance of combined and multimodality approaches for clinical success.
Main Methods:
- Review of preclinical studies on gene therapy strategies for thyroid cancer.
- Analysis of targeted therapeutic gene delivery systems.
- Evaluation of combined gene therapy and conventional treatment regimens.
Main Results:
- Several gene therapy strategies have shown preclinical feasibility for thyroid cancer.
- Targeted gene delivery shows promise for overcoming treatment resistance.
- Combined gene therapy approaches are suggested for enhanced clinical efficacy.
Conclusions:
- Gene therapy represents a viable alternative for advanced thyroid cancers.
- Multimodality treatment combining gene therapy with conventional methods is recommended.
- Emerging thyroid cancer markers could further enhance gene therapy effectiveness.
Related Concept Videos
00:59Gene Therapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:23The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...